Analyses and presentations

Corporate Presentation

Corporate presentation October 2025

Analyses

• 06 Oct 2025 / Redeye Research Note October 6, 2025
  https://guardtherapeutics.com/assets/uploads/Redeye-Research-Note-2025-10-06.pdf
• 30 Sep 2025 / DNB Carnegie POINTER data preview September 30, 2025
  https://guardtherapeutics.com/assets/uploads/DNBCarnegie_250929_POINTER-Preview-v2.pdf
• 11 Sep 2025 / Redeye Initiation of Coverage September 11, 2025
  https://guardtherapeutics.com/assets/uploads/Redeye-Initiation-of-Coverage-250911.pdf
• 25 Aug 2025 / Carnegie Access 22 August, 2025
  https://guardtherapeutics.com/assets/uploads/Carnegie_250822.pdf
• 14 May 2025 / Carnegie Access 14 May, 2025
  https://guardtherapeutics.com/assets/uploads/Carnegie_250514.pdf
• 08 Apr 2025 / Carnegie Access 8 April, 2025
  https://guardtherapeutics.com/assets/uploads/Carnegie_250408.pdf

Presentations & interviews

• 16 Sep 2025 / CEO Tobias Agervald appears on BiotechTV
  https://www.biotechtv.com/post/guard-therapeutics-september-16-2025
• 17 Oct 2024 / Guard presents at Redeye Theme "Cardiovascular & Metabolic Diseases Event 2024"
  https://www.redeye.se/videoiframe/1044029
• 23 Sep 2024 / CEO Tobias Agervald appears on BiotechTV
  https://www.biotechtv.com/post/guard-therapeutics-september-21-2024
• 19 Sep 2024 / Presentation at Pareto Securities' 15th Annual Healthcare Conference
  https://guardtherapeutics.com/assets/uploads/Guard-Tx-Pareto-19Sept2024-final.pdf
• 30 Jan 2024 / Guard Therapeutics R&D update January 30, 2024
  https://youtube.com/live/Enob5jUFw8I
• 23 Nov 2023 / Tobias Agervald presents at ABGSC Investor Days
  https://www.youtube.com/watch?v=e2-bDLGMznk&list=PLgLifPc-PiGOhe-TjD_5jry8sc-EVJAoK&index=38